EUVIMEDEUVIMED entdecken
Crossref

Skin cancer characteristics during the first year of the COVID‐19 pandemic at a tertiary hospital in Latin America

Lucas S P Pauvels iD, Arthur B Fiegenbaum, Renato M Bakos

International Journal of Dermatology · 2023

DOI: 10.1111/ijd.16848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, 2023. Verfasst von Lucas S P Pauvels und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Skin Neoplasms, COVID-19, Basal Cell Carcinoma, Melanoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The influence of the novel human coronavirus disease (COVID‐19) pandemic on skin cancer characteristics in Latin America is still poorly elucidated.

Methods

This was a cross‐sectional study which included patients diagnosed with skin cancer (basal cell carcinoma [BCC], cutaneous squamous cell carcinoma [cSCC], and primary cutaneous melanoma [cMM]) during the first year of the COVID‐19 pandemic (from March 1, 2020, to February 28, 2021) and the preceding year at our institution. The total number of skin cancer diagnoses and surgeries, as well as their topography, clinicopathological staging at diagnosis, and treatment delay were compared between the two periods.

Results

There was a 31.8% reduction in skin cancer diagnoses during the first year of the COVID‐19 pandemic at our institution. There was an increase in the proportion of low‐risk cancers according to the NCCN guidelines for BCCs (40.8–49%, P < 0.001) and cSCCs (41.7–49.6%, P = 0.03), but there was no difference in the distribution of other staging systems for the three types of cancer. We also found a significant reduction in surgeries for BCCs (−57.6%, P < 0.001) and cSCCs (−44.7%, P < 0.001) but not for cMM.

Conclusions

The first year of the COVID‐19 pandemic was associated with reduced numbers of skin cancer diagnoses and surgeries at our institution. This study provides an assessment of skin cancer characteristics during the first year of the pandemic in the Latin American population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsCOVID-19Basal Cell CarcinomaMelanomaCarcinoma, Squamous CellHumansCross-Sectional StudiesTertiary Care CentersLatin AmericaMaleFemaleMiddle AgedNeoplasm StagingAgedTime-to-TreatmentSARS-CoV-2Adult

Autor:innen und Institutionen

  • Department of Dermatology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • Department of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

ORCID-Profile: Lucas S P Pauvels

Zitieren

APA

Pauvels, L. S. P., Fiegenbaum, A. B., & Bakos, R. M. (2023). Skin cancer characteristics during the first year of the COVID‐19 pandemic at a tertiary hospital in Latin America. International Journal of Dermatology. https://doi.org/10.1111/ijd.16848

Vancouver

Pauvels LSP, Fiegenbaum AB, Bakos RM. Skin cancer characteristics during the first year of the COVID‐19 pandemic at a tertiary hospital in Latin America. International Journal of Dermatology. 2023. doi:10.1111/ijd.16848

BibTeX
@article{Pauvels2023,
  author = {Pauvels, Lucas S P and Fiegenbaum, Arthur B and Bakos, Renato M},
  title = {Skin cancer characteristics during the first year of the COVID‐19 pandemic at a tertiary hospital in Latin America},
  journal = {International Journal of Dermatology},
  year = {2023},
  doi = {10.1111/ijd.16848}
}
Kostenlos starten →